<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0018">
 <label>18</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0018">
  <string-name>
   <surname>Dang</surname>
   <given-names>NH</given-names>
  </string-name>, 
  <string-name>
   <surname>Pro</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Hagemeister</surname>
   <given-names>FB</given-names>
  </string-name>, et al. 
  <article-title>Phase II trial of denileukin diftitox for relapsed/refractory T‐cell non‐Hodgkin lymphoma</article-title>. 
  <source>Br J Haematol</source>. 
  <year>2007</year>;
  <volume>136</volume>:
  <fpage>439</fpage>‐
  <lpage>447</lpage>.
  <pub-id pub-id-type="pmid">17233846</pub-id>
 </mixed-citation>
</ref>
